Fusidic acid pharmacology, pharmacokinetics and pharmacodynamics.
about
A new strategy to fight antimicrobial resistance: the revival of old antibioticsFusidic acid is an effective treatment against Toxoplasma gondii and Listeria monocytogenes in vitro, but not in mice.Dumb and dumber--the potential waste of a useful antistaphylococcal agent: emerging fusidic acid resistance in Staphylococcus aureus.'Old' antibiotics for emerging multidrug-resistant bacteriaLiposomal fusidic acid as a potential delivery system: a new paradigm in the treatment of chronic plaque psoriasis.Population pharmacokinetics of fusidic acid: rationale for front-loaded dosing regimens due to autoinhibition of clearanceFusidic acid viscous eyedrops--an evaluation of pharmacodynamics, pharmacokinetics and clinical use for UK optometrists.Are antibiotic drugs well prescribed in case of renal insufficiency? A retrospective study.Efforts to support the development of fusidic acid in the United States.A Critical Review of the Properties of Fusidic Acid and Analytical Methods for Its Determination.Fusidic Acid: A Bacterial Elongation Factor Inhibitor for the Oral Treatment of Acute and Chronic Staphylococcal Infections.The Antimicrobial Agent Fusidic Acid Inhibits Organic Anion Transporting Polypeptide-Mediated Hepatic Clearance and May Potentiate Statin-Induced Myopathy.Fusidic Acid Inhibits Hepatic Transporters and Metabolic Enzymes: Potential Cause of Clinical Drug-Drug Interaction Observed with Statin Coadministration.Identification and characterization of mefloquine efficacy against JC virus in vitro.Screening of drug metabolizing enzymes for fusidic acid and its interactions with isoform-selective substrates in vitro.Phospholipid structured microemulsion as effective carrier system with potential in methicillin sensitive Staphylococcus aureus (MSSA) involved burn wound infection.Colistin and Fusidic Acid, a Novel Potent Synergistic Combination for Treatment of Multidrug-Resistant Acinetobacter baumannii Infections.A central interdomain protein joint in elongation factor G regulates antibiotic sensitivity, GTP hydrolysis, and ribosome translocation.Preliminary results of a new antibiotic susceptibility test against biofilm installation in device-associated infections: the Antibiofilmogram®.Rhabdomyolysis secondary to interaction between atorvastatin and fusidic acid.Pharmacokinetics of fusidic acid and cefepime in heart tissues: implications for a role in surgical prophylaxis.In vitro activity of fusidic acid (CEM-102, sodium fusidate) against Staphylococcus aureus isolates from cystic fibrosis patients and its effect on the activities of tobramycin and amikacin against Pseudomonas aeruginosa and Burkholderia cepaciaAddition of fusidic acid impregnated bone cement to systemic teicoplanin therapy in the treatment of rat osteomyelitis.The potent mechanism-based inactivation of CYP2D6 and CYP3A4 with fusidic acid in in vivo bioaccumulation.Sodium fusidate-poly(D,L-lactide-co-glycolide) microspheres: preparation, characterisation and in vivo evaluation of their effectiveness in the treatment of chronic osteomyelitis.Targeting PRPK Function Blocks Colon Cancer Metastasis.Synthesis of fusidic acid bioisosteres as antiplasmodial agents and molecular docking studies in the binding site of elongation factor-G
P2860
Q21131083-C6DECB04-DF2F-4367-9B37-9FD49446140BQ33896529-8321422E-A434-4B33-916E-6EB62126FE76Q34481625-AAC09872-AABE-4190-85B7-55AF5DDACCB5Q34565772-EFFA75DD-6EE0-4F3F-9F28-F14F5E80DC80Q35848232-6293899E-5628-4E8E-B3C9-99C562EEC82BQ36505360-CAE6283A-D107-42A3-AA3B-73848AEFE6BAQ36515459-48388C41-ECF6-484C-A3B7-BDAEB558F237Q37027422-962B6FD3-7204-4BB0-8EC8-9C8CF7C230E8Q38428027-EEEFFD19-706D-4C9E-9B8A-470437C083F6Q38580284-548D2086-5015-4DBE-83C6-1C312CAC6D9DQ38686596-7EBEE398-2A6C-4C51-A4B4-CC981AF5E99AQ38793280-382C89B5-F5E3-464B-B4E2-0DA110360E8AQ39560018-7EF7A44E-2771-48F2-BBD0-9B2F61192513Q39877627-5701F3AB-40F6-49AA-8C9D-07FB97257B78Q40559996-230B8A4A-3CE4-4812-B1E3-D5BF70E8B1B6Q41205322-826ED5FD-40A9-4887-96B1-745C16E18E21Q41220559-DE31C16F-C425-4677-9E9E-77F69A76C197Q41833328-11DC9F1D-45B4-4696-A662-DA6232607303Q42102366-EF327654-35E0-40E5-9FE4-A9CD28586030Q42128289-115C53D1-13A5-4496-8D55-BF8294F8D9F3Q42664007-C4A72E57-3B6E-431A-B207-528AB88FCF00Q42727109-970F2B83-7D52-41FB-9D38-968613E6FFB0Q44839678-B390137F-7B69-4CEE-829E-FEDB0D7B5C4BQ50063407-9E04673F-0844-4B43-9496-F118A2DB8BCFQ50951044-15354A9A-AB70-4DE0-9D1A-B1AE78330E90Q52684446-DD8F43B2-180D-4301-AE10-CDE83A78DC1BQ58866928-E8BD2F40-6043-47EB-B368-7973B2567528
P2860
Fusidic acid pharmacology, pharmacokinetics and pharmacodynamics.
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Fusidic acid pharmacology, pharmacokinetics and pharmacodynamics.
@ast
Fusidic acid pharmacology, pharmacokinetics and pharmacodynamics.
@en
type
label
Fusidic acid pharmacology, pharmacokinetics and pharmacodynamics.
@ast
Fusidic acid pharmacology, pharmacokinetics and pharmacodynamics.
@en
prefLabel
Fusidic acid pharmacology, pharmacokinetics and pharmacodynamics.
@ast
Fusidic acid pharmacology, pharmacokinetics and pharmacodynamics.
@en
P1476
Fusidic acid pharmacology, pharmacokinetics and pharmacodynamics.
@en
P2093
Turnidge J
P304
P356
10.1016/S0924-8579(98)00071-5
P478
12 Suppl 2
P577
1999-08-01T00:00:00Z